Precision oncology in non-small-cell lung cancer: opportunities and challenges
- PMID: 29599475
- DOI: 10.1038/s41571-018-0008-0
Precision oncology in non-small-cell lung cancer: opportunities and challenges
Similar articles
-
Precision medicine in oncology: what is it exactly and where are we?Per Med. 2018 Sep;15(5):351-353. doi: 10.2217/pme-2018-0036. Epub 2018 Sep 27. Per Med. 2018. PMID: 30260312 No abstract available.
-
Precision medicine strategies in oncology: mixed approaches to matched therapies.Future Oncol. 2018 Jan;14(2):105-109. doi: 10.2217/fon-2017-0524. Epub 2017 Dec 11. Future Oncol. 2018. PMID: 29224361 No abstract available.
-
Editorial--Accelerating precision oncology in the 21st century.Surg Oncol. 2015 Dec;24(4):359-60. doi: 10.1016/j.suronc.2015.11.001. Epub 2015 Nov 9. Surg Oncol. 2015. PMID: 26608412 No abstract available.
-
Precision medicine in pediatric oncology.Curr Opin Pediatr. 2018 Feb;30(1):17-24. doi: 10.1097/MOP.0000000000000570. Curr Opin Pediatr. 2018. PMID: 29189430 Free PMC article. Review.
-
Toward individualized treatment in urologic oncology.Urol Oncol. 2015 Apr;33(4):170. doi: 10.1016/j.urolonc.2014.10.005. Epub 2015 Feb 4. Urol Oncol. 2015. PMID: 25661236 Review. No abstract available.
Cited by
-
The Local Anesthetic Bupivacaine Inhibits the Progression of Non-Small Cell Lung Cancer by Inducing Autophagy Through Akt/mTOR Signaling.Front Oncol. 2021 Mar 11;11:616445. doi: 10.3389/fonc.2021.616445. eCollection 2021. Front Oncol. 2021. PMID: 33777755 Free PMC article.
-
Mitophagy bridges DNA sensing with metabolic adaption to expand lung cancer stem-like cells.EMBO Rep. 2023 Feb 6;24(2):e54006. doi: 10.15252/embr.202154006. Epub 2022 Nov 23. EMBO Rep. 2023. PMID: 36416244 Free PMC article.
-
Targeting the DNA Damage Response Machinery for Lung Cancer Treatment.Pharmaceuticals (Basel). 2022 Nov 27;15(12):1475. doi: 10.3390/ph15121475. Pharmaceuticals (Basel). 2022. PMID: 36558926 Free PMC article. Review.
-
NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer.Bioengineered. 2022 Jun;13(6):14413-14425. doi: 10.1080/21655979.2022.2086375. Bioengineered. 2022. PMID: 36694434 Free PMC article.
-
The emerging potentials of lncRNA DRAIC in human cancers.Front Oncol. 2022 Aug 4;12:867670. doi: 10.3389/fonc.2022.867670. eCollection 2022. Front Oncol. 2022. PMID: 35992823 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources